Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2000Medical MycologyOpen Access

In vitro antifungal susceptibility methods and clinical implications of antifungal resistance

View Full Paper
Ask AI
Bookmark
Share

Authors

AEAna Espinel‐IngroffVirginia Commonwealth University Medical CenterDWDavid W. WarnockUniversity of Alabama at BirminghamJVJosé A. VázquezAugusta University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Espinel‐Ingroff et al. (2000) studied this question.

synapsesocial.com/papers/6a704f0ba2d7cf2e39c2a577https://doi.org/10.1080/mmy.38.s1.293.304
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Increase in<i>Candida krusei</i>Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole1991 · 947 citations
  2. 2Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections1997 · 865 citations
  3. 3Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata1995 · 126 citations
  4. 4Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique1996 · 45 citations
  5. 5Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection1997 · 237 citations